Myndlift

Myndlift operates at the intersection of digital mental health, neuroscience software, consumer wellness and medical-device-enabled care. Its stated differentiation is the integration of EEG-derived brain metrics, neurofeedback training, behavioral psychology and clinician or Neuro Coach guidance in one system. That model gives it a broader workflow than a standalone meditation app or a hardware-only neurofeedback product: individuals can train at home while providers monitor assessments, symptoms and progress. The company also supports research use cases through customizable protocols and data logging. Instead, Myndlift’s position can be assessed by its breadth of stakeholders: tens of thousands of individuals, hundreds of mental-health providers and a research audience are all referenced in its company description. Its 2014 founding date, five recorded funding rounds and $5.88 million in total funding indicate an established but relatively modestly capitalized specialist rather than a heavily funded horizontal digital-health platform. The main strategic question is whether its combined hardware, software and clinical-support model can scale efficiently while maintaining evidence quality and regulatory credibility.

Myndlift was founded in 2014 and raised capital across five recorded rounds between June 30, 2015 and December 30, 2020. The disclosed amounts include $880,000 in 2015, $1.1 million in 2017 and $3.9 million in the December 2020 Series A; two additional seed rounds have no publicly stated amounts. Total funding is listed at $5.88 million, with 500 Global identified as a lead investor in the 2017 round. The company’s trajectory appears to have shifted from early product and market development toward provider distribution and accumulated clinical usage. Its product scope now spans a home neurofeedback device, the Myndlift app, personalized Neuro Coach support, a clinician platform and a research program. The strongest later inflection point is the June 2025 report of more than 1 million neurofeedback sessions delivered with clinical partners worldwide, while website content cites more than 1.6 million neurotherapy sessions. That usage evidence indicates continued activity despite the absence of a disclosed financing event since 2020. The careers page suggests ongoing recruitment interest, but no specific hiring function is disclosed.